Dian Diagnostics Group Co Ltd operates within the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Dian Diagnostics Group Co Ltd with three other
pharmaceutical manufacturers in Asia:
sales of 111.24 billion Japanese Yen [US$1.04 billion]
of which 95%
was Testing business),
Dr. Lal PathLabs Ltd
(9.12 billion Indian Rupees [US$138.86 million]
of which 100%
was Healthcare), and
Falco Holdings Co Ltd
based in Japan
(45.97 billion Japanese Yen [US$428.91 million]
of which 61%
was Medical Test).
During the year ended December of 2017, sales at
Dian Diagnostics Group Co Ltd were 5.00 billion Chinese Renmimbi (US$797.61 million).
increase of 30.9%
versus 2016, when the company's sales were 3.82 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Dian Diagnostics Group Co Ltd
(and since 2012, sales have increased a total of 610%).
Sales of Service saw an increase
36.7% in 2017, from
1.47 billion Chinese Renmimbi to 2.01 billion Chinese Renmimbi.